Biomarker May Flag Humira Responders in Hidradenitis Suppurativa
Dermatology > > General Dermatology-- Patients' C-reactive protein levels likewise show substantially greater BMI and illness intensity
by Kate Kneisel, Contributing Writer, MedPage Today January 12, 2025
Serum level of inflammatory marker C-reactive protein (CRP) anticipated reaction to adalimumab (Humira) treatment for clients with hidradenitis suppurativa, post hoc analysis of the PIONEER I and II trials discovered.
At 12 weeks of follow-up, grownups with raised CRP (specified as >> 0.30 mg/dL) at standard-- whose illness was likewise more serious-- had lower chances of medical reaction (OR 0.53, 95% CI ...